Molecular Imaging Market Trend- Rapid Integration of Nano-Biotechnology and Robotics in the Healthcare Sector
14 Jun 2022
Increasing prevalence of chronic and acute diseases such as cancer, respiratory diseases, cardiovascular disorders, rapid technological advancements in molecular imaging modalities, and rising geriatric population are some key factors expected to drive global Molecular Imaging market growth.
According to Emergen Research, the global molecular imaging market size was USD 7,058.7 million in 2019 and is expected to reach USD 10.71 billion in 2027 and register a steady revenue CAGR of 5.3% during the forecast period, 2020-2027.
Market Dynamics:
Molecular imaging is a growing biomedical field that enables identification, characterization, and quantification of biological processes taking place at molecular as well as cellular levels using a contrast agent inserted in the patient’s bloodstream. Ultrasound, magnetic resonance imaging, optical imaging, and nuclear imaging techniques are some of the widely used molecular imaging modalities. Over the recent years, there has been a rapid increase in the adoption of advanced molecular imaging systems for diagnosis of complex and rare diseases including cancer, brain disorders, lung diseases, and cardiovascular disorders among others.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @
Factors such as rising awareness about early diagnosis and treatment, improving healthcare infrastructure, growing demand for advanced molecular imaging modalities in hospitals and clinics, and increasing investments in developing more advanced systems are expected to drive global market growth.
However, high costs of advanced molecular imaging systems, low awareness about the benefits of molecular imaging technology and lack of budget to deploy advanced imaging modalities are some key factors that can hamper overall market growth to a certain extent during the forecast period.
COVID-19 Impact Analysis
Social distancing and restrictions severely disrupted businesses and operations
Lockdowns caused disruptions in transportation and logistics
Impacted manufacturing activities and mining operations globally
Took a toll on economy of various countries
Caused sudden and drastic downturn in economic activity
Disrupted agriculture, fisheries, dairy, and other sectors
Caused loss of employment and financial crisis
Supply impacts were further compounded owing to reduced disposable income
Emergence of variants continue to cause concerns and impact normal routines
Oncology Segment to Account for Largest Revenue Share:
The oncology segment is expected to account for largest revenue share during the forecast period. This can be attributed to rising prevalence of different types of cancer across the globe, increasing awareness about early diagnosis and treatment, and rising application of molecular imaging in cancer diagnosis.
Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @
Hospitals and Clinics Segment To Register Rapid Revenue CAGR:
The hospitals and clinics segment is expected to register rapid revenue CAGR over the forecast period owing to large patient pool, increasing hospital admissions, and rising adoption of advanced imaging modalities in medium to large scale clinics and hospitals across the globe.
North America to Lead In Terms of Revenue Share:
North America is expected to account for largest revenue share in the global market owing to factors such as rising incidence of chronic diseases across the globe, rapid adoption of advanced imaging technologies, presence of well-developed healthcare facilities, and rising R&D investments.
Major Companies in the Market Include:
Canon Inc.
Digirad Corporation
General Electric Company
PerkinElmer Inc.
Siemens Healthineers Inc.
Bruker Corporation
Cardinal Health
Thermo Fisher Scientific
Advanced Accelerator Applications
DDD-Diagnostics A/S
Browse Full Report Description + Research Methodology + Table of Content + Infographics@
For the purpose of this report, Emergen Research has segmented the global molecular imaging market on the basis of product type, application, end-users, and region:
Product Type Outlook (Revenue, USD Billion; 2017-2027)
Positron Emission Tomography
Single Photon Emission Computed Tomography
Magnetic Resonance Imaging
Computed Tomography
Others
Application Outlook (Revenue, USD Billion; 2017-2027)
Oncology
Cardiovascular Diseases
Neurology
Respiratory Diseases
Others
End-Users Outlook (Revenue, USD Billion; 2017-2027)
Hospitals & Clinics
Ambulatory Surgical Centers
Diagnostic Centers
Regional Outlook (Revenue, USD Billion; 2017–2027)
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
BENELUX
Italy
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
U.A.E.
South Africa
Turkey
Rest of MEA
Looking to Purchase Reports in Bundle [Schedule a Call with An Analyst]@
Read our Publication on different Websites:
Emergen Research issuu Account
Emergen Research yumpu Account
Emergen Research fogbugz Account
Emergen Research conifer.rhizome Account
Emergen Research substack Account
Emergen Research yumpu Account
Emergen Research plaza.rakuten Account
Emergen Research 3dprinting.stackexchange Account
Emergen Research weebly Account
Emergen Research cylex-canada Account
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend’s existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web:
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights:
Explore Our Custom Intelligence services | Growth Consulting Services
Press Release Available @
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.